NCT04538261

Brief Summary

This is a prospective, randomized double-blind clinical trial evaluating the effect of a balloon device (Fetal Pillow) to elevate the fetal buttocks during external cephalic version procedures. Eligible study population: nulliparous pregnant women between 37-40 weeks estimated gestational age with a breech presenting fetus and no contraindications to external cephalic version.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 17, 2020

Completed
18 days until next milestone

First Posted

Study publicly available on registry

September 4, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2020

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2023

Completed
2.3 years until next milestone

Results Posted

Study results publicly available

June 3, 2025

Completed
Last Updated

June 3, 2025

Status Verified

December 1, 2024

Enrollment Period

2.2 years

First QC Date

August 17, 2020

Results QC Date

December 12, 2024

Last Update Submit

May 29, 2025

Conditions

Keywords

BreechVersion

Outcome Measures

Primary Outcomes (1)

  • Number of Participants Having Successful Conversion to Cephalic Presentation

    Successful conversion of breech fetus to cephalic presentation

    Immediately upon completion of the ECV procedure

Secondary Outcomes (14)

  • Cesarean Delivery

    Immediately after ECV procedure or during subsequent labor and delivery

  • Fetal Presentation at Time of Delivery

    Labor and Delivery (approximately 12 hours)

  • Cost of ECV Procedure and Hospital Stay (Mother)

    ECV procedure and during labor, delivery, and immediate postpartum period (up to 42 days)

  • Cost of ECV Procedure and Hospital Stay (Neonate)

    Birth to hospital discharge (up to 42 days)

  • Shoulder Dystocia

    Labor and Delivery (approximately 12 hours)

  • +9 more secondary outcomes

Study Arms (2)

Control

SHAM COMPARATOR

Non-inflation of the balloon device

Device: Fetal Pillow insertion

Intervention

EXPERIMENTAL

Inflation of the balloon device

Device: Fetal Pillow insertion

Interventions

Inflation of balloon device used to elevate fetal buttocks prior to performing external cephalic version procedure

ControlIntervention

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women delivering at AdventHealth Orlando campus.
  • Breech presenting part as diagnosed by bedside sonography.
  • No prior deliveries \>/= 20 weeks gestational age.
  • Pregnancy is between 37-40 weeks gestational age.
  • Live fetus.
  • Patient is \>/= age 18.
  • Patient speaks English or Spanish as primary language.
  • Patient able to understand verbal and written consent

You may not qualify if:

  • Non-breech presentation (cephalic, transverse, oblique).
  • More than 1 fetus.
  • Cervical dilation of \>/= 1cm.
  • Prior uterine incision.
  • Congenital uterine anomaly.
  • Body mass index more than 40 kg/m2.
  • Uterine fibroids causing soft tissue dystocia.
  • Extended fetal neck.
  • Oligohydramnios (4-quadrant amniotic fluid index \</= 5cm).
  • Spontaneous rupture of membranes.
  • Any contraindication to vaginal delivery.
  • Intrauterine growth restriction (estimated fetal weight \</= 10%ile).
  • Estimated fetal weight \> /= 5,000 grams for non-diabetic patient or \>/= 4,500 grams for patient with pre-existing or gestational diabetes, confirmed by ultrasound.
  • Fetal gastroschisis.
  • Fetal neural tube defect.
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AdventHealth Orlando

Orlando, Florida, 32804, United States

Location

Related Publications (5)

  • External Cephalic Version: ACOG Practice Bulletin, Number 221. Obstet Gynecol. 2020 May;135(5):e203-e212. doi: 10.1097/AOG.0000000000003837.

    PMID: 32332415BACKGROUND
  • Seal SL, Dey A, Barman SC, Kamilya G, Mukherji J, Onwude JL. Randomized controlled trial of elevation of the fetal head with a fetal pillow during cesarean delivery at full cervical dilatation. Int J Gynaecol Obstet. 2016 May;133(2):178-82. doi: 10.1016/j.ijgo.2015.09.019. Epub 2016 Jan 15.

  • Hofmeyr GJ, Kulier R, West HM. External cephalic version for breech presentation at term. Cochrane Database Syst Rev. 2015 Apr 1;2015(4):CD000083. doi: 10.1002/14651858.CD000083.pub3.

  • Kok M, Cnossen J, Gravendeel L, van der Post J, Opmeer B, Mol BW. Clinical factors to predict the outcome of external cephalic version: a metaanalysis. Am J Obstet Gynecol. 2008 Dec;199(6):630.e1-7; discussion e1-5. doi: 10.1016/j.ajog.2008.03.008. Epub 2008 May 23.

  • Weiniger CF, Ginosar Y, Elchalal U, Sharon E, Nokrian M, Ezra Y. External cephalic version for breech presentation with or without spinal analgesia in nulliparous women at term: a randomized controlled trial. Obstet Gynecol. 2007 Dec;110(6):1343-50. doi: 10.1097/01.AOG.0000295605.38175.7b.

MeSH Terms

Conditions

Breech Presentation

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Results Point of Contact

Title
D. Ashley Hill, MD
Organization
AdventHealth Orlando

Study Officials

  • David A Hill, MD

    AdventHealth

    PRINCIPAL INVESTIGATOR
  • Ariana Mora

    AdventHealth

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Masking Details
Investigators and participants will not know whether participants have undergone inflation of the balloon device.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized trial using control and interventional arms.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 17, 2020

First Posted

September 4, 2020

Study Start

November 1, 2020

Primary Completion

January 31, 2023

Study Completion

January 31, 2023

Last Updated

June 3, 2025

Results First Posted

June 3, 2025

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

IPD will not be shared outside of research team.

Locations